dc.creatorMeza Espinoza, Juan Pablo
dc.creatorPicos Cárdenas, Verónica Judith
dc.creatorVásquez Jiménez, Erika Alejandra
dc.creatorGutiérrez Angulo, Melva
dc.creatorEsparza Flores, María Amparo
dc.creatorGonzález García, Juan Ramón
dc.date2015-07-21T19:24:38Z
dc.date2015-07-21T19:24:38Z
dc.date2005-03
dc.date.accessioned2023-07-21T21:39:27Z
dc.date.available2023-07-21T21:39:27Z
dc.identifierEspinoza, J. P. M., Cárdenas, V. J. P., Jiménez, E. A. V., Angulo, M. G., Flores, M. A. E., & García, J. R. G. (2005). A complex translocation (9;22;16)(q34;q11.2;p13) in chronic myelocytic leukemia. Cancer Genetics and Cytogenetics, 157(2), 175–177. http://doi.org/10.1016/j.cancergencyto.2004.08.009
dc.identifier2210-7762
dc.identifierDOI: http://dx.doi.org/10.1016/j.cancergencyto.2004.08.009
dc.identifierhttp://repositorio.cualtos.udg.mx:8080/jspui/handle/123456789/353
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7752036
dc.descriptionThe t(9;22) is present in almost all cases with chronic myelocytic leukemia (CML). Around 5% of these patients show complex translocations involving a third chromosome in addition to chromosomes 9 and 22. All chromosomes have participated in these variants and the BCR-ABL1 hybrid gene is always present. We describe a CML case with a new complex t(9;22;16)(q34;q11.2;p13). Seven months after imatinib treatment a karyotype showed the appearance of a clone with a standard t(9;22) in addition to the clone with the complex translocation. The b3a2 transcript of BCR-ABL1 was detected both at diagnosis and 7 months after therapy. In CML, both complex translocations and standard translocations have the same prognosis. However, these complex variants could contribute to the tumoral evolution by conferring selective advantages that, in turn, cause the preferential manifestation at diagnosis of clones with complex translocations.
dc.descriptionDoctorado en Genética Humana, Universidad de Guadalajara, División de Genética, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, México Departamento de Hematología, Hospital de Pediatría, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, México
dc.languageen
dc.publisherCancer Genetics
dc.relationCancer Genetics and Cytogenetics;Volume 157, Issue 2, Pages 175–177
dc.titleA complex translocation (9;22;16)(q34;q11.2;p13) in chronic myelocytic leukemia.
dc.typeArticle


Este ítem pertenece a la siguiente institución